Construction and expression of a human/mouse chimeric CD19 monoclonal antibody: Successful modification of a murine IgM to a chimeric IgG

Author：

Publisher： Spandidos Publications

ISSN： 1792-0981

Source： Experimental and Therapeutic Medicine, Vol.7, Iss.4, 2014-01, pp. : 849-854

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Functional inactivation of CD4+CD25 high regulatory T cells using low dose human/mouse chimeric anti-CD25 monoclonal antibody enhanced lymphokine-activated killer cells activity

By Okita Riki

Targeted Oncology, Vol. 3, Iss. 4, 2008-10 ,pp. : 227-234

Springer Publishing Company

Access to resources Recommend Favorite

Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma

By Irie Reiko Ollila David O’Day Steven Morton Donald

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 2, 2004-02 ,pp. : 110-117

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I Study of Human/Mouse Chimeric Antiganglioside GD2 Antibody ch14.18 in Patients with Neuroblastoma

By Handgretinger R. Anderson K. Lang P. Dopfer R. Klingebiel T. Schrappe M. Reuland P. Gillies S.D. Reisfeld R.A. Niethammer D.

European Journal of Cancer, Vol. 31, Iss. 2, 1995-01 ,pp. : 261-267

Elsevier

Access to resources Recommend Favorite

Unique dose-dependent effects of the human pregnancy hormone estriol on the ratio of blood IgM to IgG in female mice

By Ding Jian Zhu BaoTing

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 447-452

Spandidos Publications

Access to resources Recommend Favorite

Mechanisms of in vivo antineuroblastoma activity of human natural IgM

By Ollert M.W. David K. Vollmert C. Juhl H. Erttmann R. Bredehorst R. Vogel C.-W.

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 1942-1948

Elsevier

Access to resources Recommend Favorite